Takip et
Dinesh Kadariya
Dinesh Kadariya
University of Florida
jax.ufl.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction
A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ...
Journal of the American Heart Association 9 (5), e014941, 2020
2352020
Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
BW Van Tassell, J Canada, S Carbone, C Trankle, L Buckley, ...
Circulation: Heart Failure 10 (11), e004373, 2017
2112017
Il-1 blockade in patients with heart failure with preserved ejection fraction: Results from dhart2
BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ...
Circulation: Heart Failure 11 (8), e005036, 2018
1742018
IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study
CR Trankle, JM Canada, D Kadariya, R Markley, HM De Chazal, J Pinson, ...
American journal of respiratory and critical care medicine 199 (3), 381-384, 2019
1002019
Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with …
GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ...
Journal of cardiovascular pharmacology 77 (1), 49-60, 2021
972021
Dietary fat, sugar consumption, and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction
S Carbone, JM Canada, LF Buckley, CR Trankle, HE Billingsley, ...
Basic to Translational Science 2 (5), 513-525, 2017
842017
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials
A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022
792022
Usefulness of canakinumab to improve exercise capacity in patients with long-term systolic heart failure and elevated C-reactive protein
CR Trankle, JM Canada, L Cei, N Abouzaki, C Oddi-Erdle, D Kadariya, ...
The American journal of cardiology 122 (8), 1366-1370, 2018
642018
Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
LF Buckley, JM Canada, MG Del Buono, S Carbone, CR Trankle, ...
ESC heart failure 5 (2), 372-378, 2018
622018
Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study
BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ...
Clinical cardiology 41 (8), 1004-1008, 2018
562018
Canada, JM; Carbone, S.; Roberts, CS; Abouzaki, N.; et al. Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial …
A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya
J. Am. Heart Assoc 9, e014941, 2020
552020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
S Carbone, HE Billingsley, JM Canada, E Bressi, B Rotelli, D Kadariya, ...
Diabetes/Metabolism Research and Reviews 36 (8), e3335, 2020
422020
Alirocumab in acute myocardial infarction: results from the Virginia commonwealth university alirocumab response trial (VCU-AlirocRT)
CR Trankle, G Wohlford, LF Buckley, D Kadariya, K Ravindra, R Markley, ...
Journal of cardiovascular pharmacology 74 (3), 266-269, 2019
412019
Relation of hepatic fibrosis in nonalcoholic fatty liver disease to left ventricular diastolic function and exercise tolerance
JMN Canada, A Abbate, R Collen, H Billingsley, LF Buckley, S Carbone, ...
The American journal of cardiology 123 (3), 466-473, 2019
362019
Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity and HFpEF: the UFA-preserved pilot study
S Carbone, HE Billingsley, JM Canada, D Kadariya, H Medina de Chazal, ...
JACC: Basic to Translational Science 4 (4), 563-565, 2019
322019
Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction
HE Billingsley, MG Del Buono, JM Canada, Y Kim, JI Damonte, ...
Circulation: Heart Failure 15 (10), e009518, 2022
292022
Acute effects of interleukin-1 blockade using anakinra in patients with acute pericarditis
GF Wohlford, LF Buckley, A Vecchié, D Kadariya, R Markley, CR Trankle, ...
Journal of cardiovascular pharmacology 76 (1), 50-52, 2020
292020
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
MG Del Buono, JI Damonte, CR Trankle, D Kadariya, S Carbone, ...
Scientific Reports 12 (1), 1254, 2022
282022
C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of …
J Van Wezenbeek, JM Canada, K Ravindra, S Carbone, CR Trankle, ...
Frontiers in cardiovascular medicine 5, 178, 2018
272018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics
S Carbone, JM Canada, HE Billingsley, D Kadariya, DL Dixon, ...
Diabetes, Obesity and Metabolism 20 (8), 2014-2018, 2018
272018
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20